Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

BlackRock MuniYield Fund Inc. (MYD)

15.12   -0.01 (-0.07%) 02-14 16:02
Open: 15.12 Pre. Close: 15.13
High: 15.17 Low: 15.12
Volume: 38,299 Market Cap: 709M
Blackrock Muniyield Fund Inc is a diversified, closed-end management investment company. The Fund's investment objective is to provide total return through a combination of current income and capital appreciation.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 15.202 - 15.294 15.294 - 15.362
Low: 14.898 - 15.021 15.021 - 15.113
Close: 14.959 - 15.14 15.14 - 15.274

Technical analysis

as of: 2020-02-14 4:30:57 PM
Overall:       
Stoxline posted a STRONG SELL today, same as yesterday. Downward movement continues.
Target: Six months: 17.74     One year: 17.94
Support: Support1: 14.92    Support2: 12.41
Resistance: Resistance1: 15.19    Resistance2: 15.36
Pivot: 15.14
Moving Average: MA(5): 15.21     MA(20): 15.11
MA(100): 14.76     MA(250): 14.53
MACD: MACD(12,26): 0.09     Signal(9): 0.10
Stochastic oscillator: %K(14,3): 54.55     %D(3): 71.20
RSI: RSI(14): 54.68
52-week: High: 15.36  Low: 13.69  Change(%): 9.4
Average Vol(K): 3-Month: 7152  10-Days: 6348

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
MYD has closed above bottom band by 44.8%. Bollinger Bands are 0.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2020-02-13
Myriad Genetics (MYGN) Files for myChoice CDx Test sPMA
With the receipt of the regulatory approval, Myriad Genetics (MYGN) will be taking a major stride forward in its Oncology and Women's Health segment.

2020-02-07
The Law Offices of Frank R. Cruz Announces Investigation on Behalf of Myriad Genetics, Inc., Investors (MYGN)
LOS ANGELES--(BUSINESS WIRE)---- $MYGN #classaction--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Myriad Genetics, Inc., (“Myriad” or the “Company”) (NASDAQ: MYGN) concerning whether the board breached its fiduciary duties to shareholders. If you are a shareholder, click here to participate. Follow us for updates on Twitter: twitter.com/FRC_LAW. If you own Myriad shares and wish to discuss this matter with us, or have any questions concerning your rights and int

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Financial Services
Industry:  Asset Management
Shares Out. (M) 46.92
Shares Float (M)
% Held by Insiders
% Held by Institutions 10.40
Shares Short (K) 20
Shares Short P. Month (K)

Stock Financials

EPS 1.570
Book Value (p.s.) 14.890
PEG Ratio
Profit Margin 154.33
Operating Margin 87.56
Return on Assets (ttm) 2.4
Return on Equity (ttm) 10.9
Qtrly Rev. Growth -6.9
Gross Profit (p.s.) 1.053
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth 6431.20
Operating Cash Flow (M) 59.72
Levered Free Cash Flow (M) 12.59

Stock Valuations

P/E 9.63
P/E Growth Ratio
P/BV 1.02
P/S 14.82
P/CF 11.88

Dividends & Splits

Dividend 0.360
Dividend Yield 0.02
Dividend Pay Date 2019-01-31
Ex-Dividend Date 2020-01-13
Forward Dividend 0.670
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.